| |
 |
|
|
Bridgehead
International
US Expansion
continues
November 2008
Michael Paas joins Bridgehead International New York office
Michael Paas has joined Bridgehead International
as Senior VP, Bridgehead USA Inc. and will head up the company's
New York office.
Michael has extensive
experience in developing pricing, market access, and commercial
strategies for domestic (US) and international pharmaceutical,
biotech and medical device clients for both pipeline and in-line
products. Prior to joining Bridgehead, Michael was Principal,
Pricing and Market Access Strategy at IMS Consulting, formerly
known as Cambridge Pharma Consultancy. Before joining Cambridge,
he ran his own life science-focused strategic consultancy
and business development firm, which he formed after spending
several years as a management consultant with A.T. Kearney
in New York; Michael began his career in consulting at Deloitte
Touche Tohmatsu Int'l in Japan.
Michael's expertise spans a number of therapeutic areas including oncology and oncology supportive care, cardiovascular, respiratory, CNS, metabolism, antivirals and surgical supportive care. In addition to his extensive expertise in the US and Japanese markets, Michael has broad project experience in the major healthcare markets of Europe and Asia, as well as key emerging markets.
Michael holds a Bachelors degree in Natural Sciences/Biophysics from The Johns Hopkins University, a Masters in Public Health in Environmental Health Sciences from the Columbia School of Public Health and an MBA in Finance and International Business from the Columbia Business School. He speaks advanced Japanese, and is conversant in Chinese, French and German.
|
|
Bridgehead International CEO,
Timothy Fitzgerald commented: "Michael represents
an important addition to the US management team at a time
when we are pushing ahead with a major expansion of our activities
in North America. His expertise and experience, particularly
in market access and reimbursement, will be of real value
to Bridgehead and our clients."
Whilst much of Bridgehead's work
on pricing, reimbursement and market access is global in nature
(US, top five Europe and Japan), the company is being asked
increasingly to use its knowledge and experience to address
US-specific issues, through:
- Payer research
- Therapy area scanning
- Pricing strategy for commercialisation
- Reimbursement negotiation strategy
- Product life cycle pricing strategy
- Pharmacoeconomic assessments
- Health technology assessment support
Top
|
About Bridgehead International
Bridgehead
International works with commercial organisations,
government agencies and the investment community to ensure
that:
- Life science companies have the funding,
structure and strategic focus to deliver high levels of
innovation and financial return.
- Patients have rapid and broad access
to new innovative medicines, medical devices and diagnostic
tools, particularly in areas of high unmet need.
With over 50 consultants and associates
in Europe, North America and Asia, Bridgehead
provides a powerful combination of strategic, scientific,
medical, technical, commercial, economic, decision support,
modelling and intellectual property skills and experience.
|
